Ventyx Biosciences has shared promising top-line results from a phase 2a study of its investigational central nervous system ...

Boehringer Ingelheim’s Spevigo (spesolimab) has been recommended by the National Institute for Health and Care Excellence ...

While AI’s influence is growing across drug discovery, clinical trials and supply chains, it doesn’t provide that ...

Imagine MedEd that thinks, adapts, and delivers unprecedented insights. Better yet, experience if for yourself in our ...

The use of AI in pharma can expedite drug development and manufacturing, enabling novel medicines to get to underserved ...

Galderma’s Nemluvio (nemolizumab) has demonstrated sustained and clinically meaningful improvements in the key signs and ...

The US Food and Drug Administration (FDA) has approved CSL’s Andembry (garadacimab-gxii) to prevent attacks of hereditary ...

Gilead Sciences’ twice-yearly injectable pre-exposure prophylaxis (PrEP) drug has been approved by the US Food and Drug ...

GCI Health has announced the appointment of Aneeb Sharif as Europe, Middle East and Africa (EMEA) head of policy. Sharif holds more than 15 years of experience in healthcare policy analysis, strategic ...

AstraZeneca (AZ) has announced promising results from a late-stage study of its C5 complement inhibitor Ultomiris ...

For years, women have been significantly underrepresented in clinical trials, despite making up a large portion of patients ...

That’s why empowering local voices within global teams is mission critical. It’s not just about having someone in the seat; ...